Cassava Sciences (NASDAQ:SAVA) crashed nearly 84% following a late-stage trial setback for its ... product candidate that can detect Alzheimer’s disease from a blood sample.

It's hard to trust the disease statistics when cognitive tests often are not completed, write Robert Brownell and Dr. Yogesh ...

At a press conference last week, Dr Heather Jarrell, New Mexico's chief medical examiner, said Arakawa died of hantavirus ...

Annovis Bio Inc. (NYSE: ANVS), a clinical-stage drug platform company trading near its 52-week low of $2.99, has announced the initiation of a Phase 3 trial for its Alzheimer's disease (AD ...

Opens in a new tab or window With early diagnosis of Alzheimer's disease comes the possibility of treatment to not only help manage symptoms but also slow progression to a more advanced stage.

AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...

Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its initial stages. BillionPhotos.com – stock.adobe.com Karikari ...

There are already millions of Dementia Friends in England and Wales! Students who complete the activities will be awarded a badge and a poster for their school. Available for Key Stage 1, 2, 3 and 4.